Towards a European production of stable isotopes for novel nuclear medicine therapies (SAMIRA/ERVI)

Expected Outcome: the project results are expected to contribute to the following outcomes: support for the development of EU production of stable isotopes that are essential for the manufacturing of radionuclides used in novel nuclear medicine therapies; strengthening of the resilience and security of the EU medical radioisotope supply chain by securing access to source materials, reducing dependence on third countries and enhancing industrial-scale production (including the sourcing of stable isotopes); leveraging of the knowledge and expertise of nuclear scientists, physicists and engineers in order to develop and optimise the processes for the EU-based production of stable isotopes, while contributing to Europe’s Beating Cancer Plan and implementing the Strategic Agenda for Medical Ionising Radiation Applications (SAMIRA). Scope: radiological and nuclear technologies are integral to modern healthcare. They play a crucial role in cancer care – from early detection and diagnosis to treatment and palliative support. They also support the diagnosis and management of a wide range of other conditions (including cardiovascular and neurological diseases). Each year, patients throughout the EU benefit from the application of nuclear medicine in the diagnosis and treatment of cancer and other serious conditions. Innovations such as targeted radionuclide therapy (also known as radioligand therapy) are reshaping medicine by enabling more precise and personalised treatment. Medical ra…bron

• Activiteiten moeten zich richten op technologiegereedheidsgraad 5 tot 7
• Voorstel moet zich richten op activiteiten dicht bij de markt (prototyping, testen, demonstreren, piloten en opschaling)
• Beperkte O&O-activiteiten zijn toegestaan
• Consortiumleden moeten uit in aanmerking komende landen komen (Annex B)

De eisen uit de regeling. Uw situatie bepaalt of u voldoet; dit is geen beschikking.

Zoals beschreven door de verstrekker. Onvolledig? Controleer altijd het officiële loket.

Geen openbare bronnen beschikbaar.